Key Developments: Express Scripts Holding Co (ESRX.O)
62.94USD
18 Jun 2013
$-0.04 (-0.06%)
$62.98
$63.14
$63.34
$62.67
3,508,795
4,866,211
$66.06
$49.79
Latest Key Developments (Source: Significant Developments)
Express Scripts Holding Co Issues FY 2014 EPS Guidance Below Analysts' Estimates-Conference Call
Express Scripts Holding Co announced that for fiscal 2014, it expects earnings per share (EPS) to be $4.14. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $4.93 for fiscal 2014. Full Article
Express Scripts Holding Co Raises FY 2013 EPS Guidance
Express Scripts Holding Co previously provided adjusted earnings per diluted share from continuing operations attributable to Express Scripts for 2013 in the range of $4.20 to $4.30, or growth of 12% to 15% over 2012. The Company expects improvements in gross profit over the balance of the year and now anticipates achieving adjusted earnings per diluted share from continuing operations attributable to Express Scripts for 2013 in the range of $4.23 to $4.33, or 13% to 16% growth over 2012. Full Article
Express Scripts Holding Co Issues FY 2013 EPS Guidance In Line With Analysts' Estimates
Express Scripts Holding Co announced that for fiscal 2013, it expects to achieve adjusted earnings per diluted share (EPS) from continuing operations in the range of $4.20 to $4.30. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $4.20 for fiscal 2013. Full Article
Express Scripts Holding Co Raises FY 2012 Earnings Guidance; Comments On FY 2013 Earnings Guidance
Express Scripts Holding Co announced that for fiscal 2012, it expects adjusted earnings per share for 2012 in the range of $3.65 to $3.75. The Company also expects to grow earnings per share and EBITDA in fiscal 2013. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $3.71 for fiscal 2012; EPS of $4.47 and EBITDA of $7.04 billion for fiscal 2013. Full Article
Express Scripts Holding Co Raises FY 2012 EPS Guidance
Express Scripts Holding Co announced that for fiscal 2012, it expects adjusted earnings per share (EPS) in the range of $3.60 to $3.75. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $3.53 for fiscal 2012. Full Article
Express Scripts Holding Co And Walgreens Announce New Pharmacy Network Agreement
Express Scripts Holding Co and Walgreens announced the companies have reached a multi-year pharmacy network agreement that includes rates and terms under which Walgreens will participate in the broadest Express Scripts retail pharmacy network available to new and existing clients. The companies are not disclosing the terms of the new contract. Walgreens will be part of the broadest network of pharmacies available to Express Scripts clients, as of September 15, 2012. Express Scripts will work to ensure a smooth transition for those plan sponsors who will want to include Walgreens pharmacies in their network. Full Article
Express Scripts Holding Co Issues FY 2012 EPS Guidance In Line With Analysts' Estimates
Express Scripts Holding Co announced that for fiscal 2012, it expects adjusted earnings per share (EPS) in the range of $3.36 to $3.66. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $3.63 for fiscal 2012. Full Article
Express Scripts, Inc. Announces Pricing Of $3.5 Billion Senior Notes Offering
Express Scripts, Inc. announced today that its wholly owned subsidiary, Aristotle Holding, Inc., a Delaware corporation ("Aristotle"), has successfully priced a private offering of senior notes consisting of $1.0 billion aggregate principal amount of 2.10% senior notes due 2015, $1.5 billion aggregate principal amount of 2.65% senior notes due 2017 and $1.0 billion aggregate principal amount of 3.90% senior notes due 2022. The offering is expected to close on February 9, 2012, subject to customary closing conditions. The net proceeds from the offering will be used to pay a portion of the cash consideration payable to stockholders of Medco Health Solutions, Inc. (Medco) in connection with the previously announced merger pursuant to which Express Scripts and Medco will each become wholly owned subsidiaries of Aristotle (Merger), to repay any existing indebtedness that will be repaid in connection with the Merger and to pay related fees and expenses. Commitments under the unsecured bridge term loan facility that Express Scripts and Aristotle entered into in connection with the financing of the Merger will automatically be reduced dollar-for-dollar by the net proceeds from the sale of the senior notes. Aristotle will be required to redeem the notes in the event that the Merger does not occur. Full Article
Express Scripts, Inc.'s Subsidiary Launches Senior Notes Offering
Express Scripts, Inc. announced that its wholly owned subsidiary, Aristotle Holding, Inc., a Delaware corporation (Aristotle), has commenced a private offering of senior notes of a benchmark amount. The net proceeds from the offering will be used to pay a portion of the cash consideration payable to stockholders of Medco Health Solutions, Inc. in connection with the previously announced merger pursuant to which Express Scripts and Medco will each become wholly owned subsidiaries of Aristotle, to repay any existing indebtedness that will be repaid in connection with the Merger and to pay related fees and expenses. Commitments under the unsecured bridge term loan facility that Express Scripts and Aristotle entered into in connection with the financing of the Merger will automatically be reduced dollar-for-dollar by the net proceeds from the sale of the senior notes. Aristotle will be required to redeem the notes in the event that the Merger does not occur. Following the Merger, Aristotle will be renamed Express Scripts Holding Company and will become a publicly traded corporation, Medco and Express Scripts will each become wholly owned subsidiaries of Aristotle and former Medco and Express Scripts stockholders will own stock in Aristotle. Full Article
Express Scripts, Inc. Reaffirms FY 2011 EPS Guidance
Express Scripts, Inc. reaffirmed its fiscal 2011 adjusted earnings per share (EPS) guidance of $2.95 to $3.05. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report EPS of $2.99 for fiscal 2011. Full Article
BRIEF-CVS still "very confident" can keep 60 pct of scripts from Walgreen-Express Scripts spat
May 1 - CVS Caremark Corp : * Still "very confident" can keep at least 60 percent of scripts in 2013 gained
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
